Costello Asset Management’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93K Hold
1,000
0.03% 175
2026
Q1
$88.9K Hold
1,000
0.03% 172
2025
Q4
$95.2K Hold
1,000
0.03% 154
2025
Q3
$98.6K Hold
1,000
0.03% 159
2025
Q2
$106K Hold
1,000
0.04% 150
2025
Q1
$91.1K Buy
+1,000
New +$112K 0.04% 160
2022
Q1
Sell
-15
Closed -$4K 244
2021
Q4
$4K Sell
15
-35
-70% -$9.59K ﹤0.01% 203
2021
Q3
$14K Sell
50
-50
-50% -$15.9K 0.01% 163
2021
Q2
$22K Hold
100
0.01% 142
2021
Q1
$11K Hold
100
0.01% 184
2020
Q4
$8K Hold
100
0.01% 187
2020
Q3
$7K Buy
+100
New +$7.17K 0.01% 177

Other funds holding BNTX

Costello Asset Management's BNTX Position: Q2 2026 in Review

Costello Asset Management held its BioNTech (BNTX) position steady in Q2 2026 at 1,000 shares worth $93K. The position accounts for 0.03% of the portfolio, ranked #175.

Costello Asset Management first reported a position in BNTX in Q3 2020 and has held it in 12 quarters since. The position peaked at $106K in Q2 2025. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Costello Asset Management held 1,000 shares of BioNTech worth $93K as of Q2 2026.
  • Costello Asset Management left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up 0.03% of Costello Asset Management's portfolio in Q2 2026, its #175 holding.
  • Costello Asset Management first reported a position in BioNTech in Q3 2020 and has held it in 12 quarters since.
  • Costello Asset Management's BioNTech position peaked at $106K in Q2 2025.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.